Overview
- Legal name
- BIOARRAY SOLUTIONS LTD
- Also known as
- BIOARRAY SOLUTIONS
- Registered location
- WARREN, NJ, USA
- Website
- Company website ↗
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- Latest award activity
- May 7, 2026
Read company summary
BIOARRAY SOLUTIONS LTD is associated with UEI UB25FLCNAPL3 and CAGE 07GW9 in public federal records. AcornBids currently links 1 prime award totaling $95.4K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as In-Vitro Diagnostic Substance Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325413 (In-Vitro Diagnostic Substance Manufacturing). Its public SAM.gov registration lists WARREN, NJ, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 13, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- BIOARRAY SOLUTIONS LTD
- Doing business as
- BIOARRAY SOLUTIONS
- UEI
- UB25FLCNAPL3
- CAGE
- 07GW9
- Registered address
- 35 TECHNOLOGY DR STE 100, WARREN, NJ, 07059, USA
- Registration status
- Active
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- SAM activation
- May 20, 2026
- Initial registration
- May 14, 2001
- Entity start
- Feb 22, 2001
- SAM updated
- May 20, 2026
- Registration expires
- May 18, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 1 awards and $95,430 in reported obligations to this legal entity. Source
- Recorded awards include In-Vitro Diagnostic Substance Manufacturing (NAICS 325413); this classification is not proof of every company capability. Source
- An example award describes: TRANSFUSION MEDICINE REAGENTS Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 1 of 1 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $-52.8K |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $-2.7K |
| Change | $-50.1K |
| Growth | Not comparable |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Health and Human Services | $-55.5K | 1 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| NATIONAL INSTITUTES OF HEALTH - CC | $-55.5K | 1 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 325413 — In-Vitro Diagnostic Substance Manufacturing | $-55.5K | 1 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| 6640 — Laboratory Equipment and Supplies | $-55.5K | 1 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $-55.5K | 1 |
States
| Category | Period obligations | Awards |
|---|---|---|
| NJ | $-55.5K | 1 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| NO SET ASIDE USED. | $-55.5K | 1 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N90019P00156TRANSFUSION MEDICINE REAGENTS | Department of Health and Human Services | $95.4K | Jan 4, 2019 | Jan 30, 2021 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | May 20, 2026 |
| Source loaded | Sep 19, 2026 |
| Initial registration | May 14, 2001 |
| Entity start | Feb 22, 2001 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325413 — In-Vitro Diagnostic Substance Manufacturing | Not reported |
| 334516 — Analytical Laboratory Instrument Manufacturing | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| THOMAS MITTLESTADT | Government business | Contact method not published | SAM registration | Not available |
| DAVE JOHNSON | Alternate government business | Contact method not published | SAM registration | Not available |
| STEVEN CARLIN | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- 334516 — Analytical Laboratory Instrument Manufacturing
Registered products and services
- 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Reported subsidiary tree
Ownership follows reported parent UEIs.
- RISING MEDICAL SOLUTIONS, LLCUEI CF9JFHZAFDJ2
- BIOARRAY SOLUTIONS LTDUEI UB25FLCNAPL3
Corporate family
Reported ownership links. Award and funding explorers can include this family.
| Legal entity | Reported parent UEI | Source loaded |
|---|---|---|
| RISING MEDICAL SOLUTIONS, LLC | — | Sep 2, 2026 |
| BIOARRAY SOLUTIONS LTD | CF9JFHZAFDJ2 | Sep 19, 2026 |
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit